Liem Robert I, Chan Cheeling, Vu Thanh-Huyen T, Fornage Myriam, Thompson Alexis A, Liu Kiang, Carnethon Mercedes R
Hematology, Oncology & Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.
Department of Pediatrics, and.
Blood. 2017 Feb 9;129(6):723-728. doi: 10.1182/blood-2016-07-727719. Epub 2016 Nov 16.
The contribution of sickle cell trait (SCT) to racial disparities in cardiopulmonary fitness is not known, despite concerns that SCT is associated with exertion-related sudden death. We evaluated the association of SCT status with cross-sectional and longitudinal changes in fitness and risk for hypertension, diabetes, and metabolic syndrome over the course of 25 years among 1995 African Americans (56% women, 18-30 years old) in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Overall, the prevalence of SCT was 6.8% (136/1995) in CARDIA, and over the course of 25 years, 46% (738/1590), 18% (288/1631), and 40% (645/1,611) of all participants developed hypertension, diabetes, and metabolic syndrome, respectively. Compared with participants without SCT, participants with SCT had similar baseline measures of fitness in cross-section, including exercise duration (535 vs 540 seconds; = .62), estimated metabolic equivalent of tasks (METs; 11.6 vs 11.7; = .80), maximum heart rate (174 vs 175 beats/min; = .41), and heart rate at 2 minutes recovery (44 vs 43 beats/min; = .28). In our secondary analysis, there was neither an association of SCT status with longitudinal changes in fitness nor an association with development of hypertension, diabetes, or metabolic syndrome after adjustment for sex, baseline age, body mass index, fitness, and physical activity. SCT is not associated with reduced fitness in this longitudinal study of young African American adults, suggesting the increased risk for exertion-related sudden death in SCT carriers is unlikely related to fitness. SCT status also is not an independent risk factor for developing hypertension, diabetes, or metabolic syndrome.
尽管有人担心镰状细胞性状(SCT)与运动相关的猝死有关,但SCT对心肺适能方面种族差异的影响尚不清楚。在“青年动脉粥样硬化风险发展研究”(CARDIA)中,我们评估了1995名非裔美国人(56%为女性,年龄在18至30岁之间)的SCT状态与25年间适能的横断面和纵向变化以及高血压、糖尿病和代谢综合征风险之间的关联。总体而言,CARDIA研究中SCT的患病率为6.8%(136/1995),在25年的研究过程中,所有参与者分别有46%(738/1590)、18%(288/1631)和40%(645/1611)患上了高血压、糖尿病和代谢综合征。与没有SCT的参与者相比,有SCT的参与者在横断面的适能基线测量结果相似,包括运动持续时间(535秒对540秒;P = 0.62)、估计的代谢当量任务(METs;11.6对11.7;P = 0.80)、最大心率(174次/分钟对175次/分钟;P = 0.41)以及恢复2分钟时的心率(44次/分钟对43次/分钟;P = 0.28)。在我们的二次分析中,在对性别、基线年龄、体重指数、适能和体力活动进行调整后,SCT状态与适能的纵向变化之间没有关联,也与高血压、糖尿病或代谢综合征的发生没有关联。在这项针对年轻非裔美国成年人的纵向研究中,SCT与适能降低无关,这表明SCT携带者运动相关猝死风险增加不太可能与适能有关。SCT状态也不是患高血压、糖尿病或代谢综合征的独立危险因素。